Cargando…
Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses
INTRODUCTION: Propensity score methods are increasingly used to address confounding related to treatment selection in observational studies. Studies estimating the effect of chemotherapy in colon cancer (CC) patients, however, often lacked information on pertinent comorbidities and functional status...
Autores principales: | Boakye, Daniel, Walter, Viola, Martens, Uwe M, Chang-Claude, Jenny, Hoffmeister, Michael, Jansen, Lina, Brenner, Hermann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733250/ https://www.ncbi.nlm.nih.gov/pubmed/31564986 http://dx.doi.org/10.2147/CLEP.S215983 |
Ejemplares similares
-
Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients
por: Boakye, Daniel, et al.
Publicado: (2021) -
Personalizing the Prediction of Colorectal Cancer Prognosis by Incorporating Comorbidities and Functional Status into Prognostic Nomograms
por: Boakye, Daniel, et al.
Publicado: (2019) -
Association between Blood 25-Hydroxyvitamin D Levels and Survival in Colorectal Cancer Patients: An Updated Systematic Review and Meta-Analysis
por: Maalmi, Haifa, et al.
Publicado: (2018) -
Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population‐based study
por: Alwers, Elizabeth, et al.
Publicado: (2020) -
Survival of patients with symptom- and screening-detected colorectal cancer
por: Brenner, Hermann, et al.
Publicado: (2016)